{"gao_id": "GAO-23-105656", "published": "2023-04-04T12:00:00Z", "released": "2023-05-04T08:00:00Z", "summary": "The National Institutes of Health\u2014the largest public funder of biomedical research in the U.S.\u2014invests billions of dollars each year to help develop new drugs or new uses for existing drugs. But the extent of NIH's contributions to drug development isn't well understood or recognized by the public. One reason may be that recipients of NIH funds aren't always disclosing agency support fully or correctly when...", "title": "National Institutes of Health: Better Data Will Improve Understanding of Federal Contributions to Drug Development", "topics": ["Database management systems", "Clinical trials", "Federal funds", "Grant programs", "Health care", "Research and development", "Medical research", "Biomedical research", "Drugs", "Science and Technology", "Federally funded research", "Use of funds", "Intellectual property rights"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-23-105656", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-23-105656-highlights.pdf"}, {"title": "Full Report (55 pages)", "url": "https://www.gao.gov/assets/gao-23-105656.pdf"}, {"title": "Accessible PDF (64 pages)", "url": "https://www.gao.gov/assets/820/818706.pdf"}]}